Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Isabell, Herrmann"'
Autor:
Anna Kanerva, Daniel T. Rein, Ari Ristimäki, Lotta Kangasniemi, Akseli Hemminki, Pekka Virkkunen, Minna Eriksson, Marius Porten, Gerd J. Bauerschmitz, Tanja Hakkarainen, Camilla Ribacka, Tuuli Ranki, Maija Tarkkanen, Sari Pesonen, Isabell Herrmann
Publikováno v:
Cancer Research. 68:5533-5539
It has been proposed that human tumors contain stem cells that have a central role in tumor initiation and posttreatment relapse. Putative breast cancer stem cells may reside in the CD44+CD24−/low population. Oncolytic adenoviruses are attractive f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea1d13835cf41af8835d4a4849aad83
https://doi.org/10.1158/0008-5472.can-07-5288
https://doi.org/10.1158/0008-5472.can-07-5288
Autor:
Devin E. Eckhoff, Michael T. Numnum, Peter Dall, Mariam A. Stoff-Khalili, Zeng B. Zhu, Alexander Stoff, J. Michael Mathis, Qiana L. Matthews, Isabell Herrmann, Angel A. Rivera, Joanne T. Douglas, David T. Curiel, Rodney P. Rocconi, Gene P. Siegal
Publikováno v:
International Journal of Cancer. 120:935-941
Conditionally replicative adenoviruses (CRAds) represent novel therapeutic agents that have been recently applied in the context of breast cancer therapy. However, deficiencies in the ability of the adenovirus to infect target tumor cells and to spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bd82e6d4c4b811ddb815413ba921dd1
https://doi.org/10.1002/ijc.22338
https://doi.org/10.1002/ijc.22338
Autor:
Paul N. Reynolds, Thomas Schöndorf, Isabell Herrmann, Daniel T. Rein, M. Breidenbach, T. Schmidt, David T. Curiel, Israel Vlodavsky, Yosef S. Haviv, Kiran N. Khan
Publikováno v:
Cancer Letters. 240:114-122
Gene therapy with adenoviral (Ad) vectors is a promising new approach in the treatment of cancer. Strategies to restrict adenoviral-mediated transgene expression are important to avoid gene transfer into normal cells. Heparanase (HPR) is overexpresse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc60af61818a873dce729bd71f4057b
https://doi.org/10.1016/j.canlet.2005.09.007
https://doi.org/10.1016/j.canlet.2005.09.007
Autor:
Mariam A, Stoff-Khalili, Angel A, Rivera, Alexander, Stoff, J, Michael Mathis, Rodney P, Rocconi, Qiana L, Matthews, Michael T, Numnum, Isabell, Herrmann, Peter, Dall, Devin E, Eckhoff, Joanne T, Douglas, Gene P, Siegal, Zeng B, Zhu, David T, Curiel
Publikováno v:
International journal of cancer. 120(4)
Conditionally replicative adenoviruses (CRAds) represent novel therapeutic agents that have been recently applied in the context of breast cancer therapy. However, deficiencies in the ability of the adenovirus to infect target tumor cells and to spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5baf735e5e68cd9c09067f38e9d434be
https://pubmed.ncbi.nlm.nih.gov/17131341
https://pubmed.ncbi.nlm.nih.gov/17131341
Autor:
Isabell Herrmann, Anna Kanerva, Dirk M. Nettelbeck, David T. Curiel, Akseli Hemminki, Artur Menzel, Kilian Guse, Gerd J. Bauerschmitz, Renee A. Desmond, Masato Yamamoto, Peter Dall, Tanja Hakkarainen
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 14(2)
Conditionally replicating adenoviruses (CRAd's) feature selective replication in and killing of tumor cells. Initial clinical studies with relatively attenuated early generation agents have resulted in promising safety and efficacy data. Nevertheless
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a6e286c63d726fa7016ed7268e4e9c
https://pubmed.ncbi.nlm.nih.gov/16580264
https://pubmed.ncbi.nlm.nih.gov/16580264
Autor:
Gerd J. Bauerschmitz, Isabell Herrmann, Dieter Niederacher, Mariam A. Stoff-Khalili, B Hanstein, Bettina Durst, Peter Dall
Publikováno v:
Cancer immunology, immunotherapy : CII. 54(1)
Purpose: The CD44 v7/8 splice variant that is frequently expressed in cervical carcinoma and rarely expressed in normal tissues displays promising properties as a target antigen for cancer immune therapy. In this study, cytotoxic T lymphocytes (CTLs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82507286897a601ba682e1d53dac771
https://pubmed.ncbi.nlm.nih.gov/15693139
https://pubmed.ncbi.nlm.nih.gov/15693139
Autor:
Minghui Wang, Ronald D. Alvarez, M. Breidenbach, Daniel T. Rein, Yuko Tsuruta, David T. Curiel, Paul N. Reynolds, Isabell Herrmann
Publikováno v:
Molecular Therapy. 9:S236
Breast cancer is a leading cause of death in the United States. Despite some advances in treatment of primary breast cancer, patients with metastatic disease still have no chance of cure and conventional treatment modalities remain palliative. Theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c63a8670c7f19811ca19682b2633ab5b
https://doi.org/10.1016/j.ymthe.2004.06.547
https://doi.org/10.1016/j.ymthe.2004.06.547